• HTA51 Broadening the Scope of Value: Evaluating Payer Perspectives and Insights on ICER's Latest Initiatives and Tools

    Jul 1, 2025, 00:00

  • PT41 Structured Evaluation of Oncology Real-World Data Quality for Practical Applications

    Jul 1, 2025, 00:00

  • CO61 Suicidal Ideation in Patients Treated With Glucagon-like Peptide 1 Receptor (GLP1) Agonists: A Retrospective Real-World Analysis

    Jul 1, 2025, 00:00

  • PCR235 Quality of Life Assessment of Patients Undergoing Hip Replacement Surgery in the Public and Private Healthcare Systems

    Jul 1, 2025, 00:00

  • CO82 Comparative Effectiveness and Safety of Factor Xa Inhibitors in Atrial Fibrillation: A Systematic Literature Review of Real-World Evidence in Europe

    Jul 1, 2025, 00:00

  • HSD38 Insights into Ophthalmology Workforce Dynamics and Procedural Trends: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • PCR200 Exploring the Impact of Exercise Variability of Mental Health: Results From the 2024 US National Health and Wellness Survey

    Jul 1, 2025, 00:00

  • RWD76 Real-World Treatment Patterns Among Patients With Scalp Psoriasis in Canada

    Jul 1, 2025, 00:00

  • EE358 Validation of a Flexible Partitioned Survival and 3-State Markov Model for Cost-Effectiveness Analyses in Oncology

    Jul 1, 2025, 00:00

  • EE496 Long-Term Cost-Effectiveness of a Mobile Health Intervention Delivered by Clinical Pharmacists and Community Health Workers for Type 2 Diabetes Management

    Jul 1, 2025, 00:00

  • PCR52 Early Patient-Reported Satisfaction in Patients Initiated on Perfluorohexyloctane for Dry Eye Disease

    Jul 1, 2025, 00:00

  • SA9 Methodological Approaches and Current Applications of Distributed Cost-Effectiveness Analysis: A Systematic Review

    Jul 1, 2025, 00:00

  • MSR98 AI-Enhanced Literature Review: Comparing Advanced Pancreatic Cancer Trial Outcomes According to Performance Status

    Jul 1, 2025, 00:00

  • PCR178 Qualitative Insights on Meaningful Change in Symptoms and Impacts for Patients With Alpha-1 Antitrypsin Deficiency

    Jul 1, 2025, 00:00

  • RWD127 The Burden of Prader-Willi Syndrome on Patients and the Healthcare System: A cross-Sectional Examination of Emergency Department Visits and Inpatient Stays in US claims

    Jul 1, 2025, 00:00

  • HPR59 Access Disparities in Maintenance Medication among Patients with Mild Asthma

    Jul 1, 2025, 00:00

  • CO86 Comparing Chemotherapy, Monotherapy, and Combination Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer Progression-Free Survival and Overall Survival: Systematic Review and Meta-Analysis

    Jul 1, 2025, 00:00

  • MSR54 Leveraging Artificial Intelligence for Thematic Analysis of Qualitative Transcripts: A Feasibility Study in Insurance Payer Interviews

    Jul 1, 2025, 00:00

  • EPH5 Disability Progression and Associated Costs in Incident Early-Onset Myasthenia Gravis Patients in France A Longitudinal Cohort Study

    Jul 1, 2025, 00:00

  • HPR41 Are Patients With Major Depressive Disorder (MDD) Getting Access to Innovation in HTA Markets? Review of Reimbursement Decisions of Pharmacotherapies for MDD in Europe, Australia, and Canada From 2001 to 2021

    Jul 1, 2025, 00:00

  • HTA16 AMCP Dossier v5.0: U.S. Payer Preferences and Utilization to Support Formulary Decision Making

    Jul 1, 2025, 00:00

  • EPH18 Estimating Lung Cancer Screening Utilization in the US Using the 2023 Behavioral Risk Factor Surveillance System Data

    Jul 1, 2025, 00:00

  • EE385 Seasonal Variation in Incidence and Outcomes of Hospitalizations with Severe Community-Acquired Bacterial Pneumonia in the U.S., 2018-2022

    Jul 1, 2025, 00:00

  • MSR154 An Illustration of the Impact of Confounding Bias On Economic Evaluations in the Context of Real-World Evaluations

    Jul 1, 2025, 00:00

  • PCR199 Measuring Patient Engagement: The Importance of a Framework

    Jul 1, 2025, 00:00

  • PT36 Psychometric Evidence Supporting the Use of the EQ-5D in Long COVID: A Systematic Review

    Jul 1, 2025, 00:00

  • PCR243 Developing a Checklist for Patient Engagement in Rare Disease Value Research

    Jul 1, 2025, 00:00

  • RWD8 Variability in Definitions and Measurement Approaches of Vaso-Occlusive Crises (VOCs) in Sickle Cell Disease (SCD): A Targeted Literature Review of Global Real-World Evidence (RWE) Studies

    Jul 1, 2025, 00:00

  • HPR88 Factors Affecting Per Capita Costs in Subdistrict Health Promotion Hospitals (SHPH) After Transfer to Provincial Administrative Organizations (PAO): A Study of Allocation Models in Thailand

    Jul 1, 2025, 00:00

  • EPH34 Systematic Literature Review on the Economic Burden of Myopia

    Jul 1, 2025, 00:00

  • MSR102 Validation Evidence of Self-Reported Measures for Healthcare Resource Utilization in Adult Populations: A Systematic Review

    Jul 1, 2025, 00:00

  • HPR77 Analysis of Real-World Evidence Use Across FDA Submissions in 2022 and 2023

    Jul 1, 2025, 00:00

  • MSR157 Analytical Approaches to Estimate Medication Persistence From Electronic Health Record Data: A Study of Tyrosine Kinase Inhibitors in Patients With Epidermal Growth Factor Receptor-Positive Advanced Non-Small Cell Lung Cancer

    Jul 1, 2025, 00:00

  • PT4 A Systematic Review on Economic Evaluations of Comparisons Between CAR-T Therapies in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Jul 1, 2025, 00:00

  • HSD12 Predictors of Therapeutic Duplication Among Older Adults in the National Social Health in Aging Project

    Jul 1, 2025, 00:00

  • PCR192 From Short-Term Relief to Long-Term Benefits: Tracking the Impact of Insulin Pumps on Fear of Hypoglycemia in people with Type 1 Diabetes Mellitus

    Jul 1, 2025, 00:00

  • HSD93 Real-World Peripheral Embolization Characteristics Among Medicare Patients

    Jul 1, 2025, 00:00

  • PCR239 Improving Patient Engagement Outcomes: A Pilot Study to Investigate the Role of Empathy in Scientific Writing

    Jul 1, 2025, 00:00

  • HSD78 Early Breast Cancer in the US and Germany: A Comparison of Real-world Screening and Treatment

    Jul 1, 2025, 00:00

  • EE387 Durability and Cost-Minimization of Reprocessed Surgical Drills

    Jul 1, 2025, 00:00

  • RWD102 Impact of Adverse Event Definitions on Real-World Detection of Oncology Immune-Related Adverse Events

    Jul 1, 2025, 00:00

  • PCR201 Comparison of Rare Disease Patient and Caregiver Disease Burden in Terms of Economic, Social, and Interpersonal Impact and Impact on Quality Of Life: Results From an International Survey

    Jul 1, 2025, 00:00

  • EE263 Population-Level Impact of Emicizumab for Hemophilia A Patients in Six Latin American (LATAM) Countries: A 25-Year Model

    Jul 1, 2025, 00:00

  • HTA77 How to Best Model Caregiver Quality of Life in Health Technology Assessments? Lessons from NICE Submissions in Multiple Sclerosis

    Jul 1, 2025, 00:00

  • EE499 Costs of Type 2 Diabetes Mellitus and Obesity in Colombian Caribbean Poor Population: A Top-Down Approach from a Cardiovascular Risk Cohort, 2020-2022

    Jul 1, 2025, 00:00

  • PCR248 Adherence to Anti-Tubercular Medications in the United States: Insights from MarketScan Data (2016-2021)

    Jul 1, 2025, 00:00

  • PCR109 Is It Time to Rethink Proxy-Reporting? Feasibility and Psychometric Considerations for Creating ObsROs That Adhere to Patient-Focused Drug Development (PFDD) Fit-for-Purpose Guidance

    Jul 1, 2025, 00:00

  • RWD98 Association of Combined Opioid and Marijuana Use with Major Depressive Disorder among Adults with Chronic Conditions in the United States (US)

    Jul 1, 2025, 00:00

  • RWD154 Healthcare Resource Utilization (HCRU) and Costs of Poly(ADP-ribose) Polymerase Inhibitors (PARPi) as First-Line Maintenance (1LM) Treatment for Ovarian Cancer (OC)

    Jul 1, 2025, 00:00

  • HPR143 Estimating the Magnitude of a Pull Incentive for Antibiotic Development Using the STEDI Value Framework: An Example From Spain

    Jul 1, 2025, 00:00

  • EE287 Cost Effectiveness of Pembrolizumab in Combination with Chemotherapy for the Treatment of Patients with Locally Advanced or Metastatic HER2-Negative Gastric or Gastroesophageal Cancer in Mexico

    Jul 1, 2025, 00:00

  • PCR124 Factors Influencing the Quality of Life of Stroke Survivors: Results of an Online Survey in the US

    Jul 1, 2025, 00:00

  • PCR54 Preferences for Rapid Access Addiction Medicine Clinics Among Individuals with Problematic Alcohol Use A Discrete Choice Experiment

    Jul 1, 2025, 00:00

  • RWD164 ASCOT: A Case Study in Generating Timely and Meaningful Canadian Real-World Evidence To Support the Data Infrastructure Necessary for Innovative Patient Access

    Jul 1, 2025, 00:00

  • EE526 Impact of Recurrence Modelling on Cost-Effectiveness of New Treatments for Early Cancers

    Jul 1, 2025, 00:00

  • EE470 Cost-Effectiveness of Gabapentin, Pregabalin, and Duloxetine in the Treatment of Painful Diabetic Neuropathy: A Real-World Data-Based Net Benefit Regression Analysis

    Jul 1, 2025, 00:00

  • RWD15 Characteristics of Patients With Minimal Residual Disease (MRD) Testing for Solid Tumors in a United States Population With Commercial or Medicare Advantage (MA) Insurance

    Jul 1, 2025, 00:00

  • EE310 Healthcare Resource Utilization by Severity of Disease Among Adult Patients With Asthma in the United States

    Jul 1, 2025, 00:00

  • PCR18 Comparative Analysis of Smartphone Application and Web-based Electronic Clinical Outcome Assessment (eCOA) Modalities

    Jul 1, 2025, 00:00

  • HTA36 Horizon Scanning for Paroxysmal Nocturnal Hemoglobinuria in Brazil: Insights on Past Trends and Future Prospects

    Jul 1, 2025, 00:00

  • EE480 Surgical Stripping and Ligation Compared to Cyanoacrylate Vein Closure in the Mexican Public Healthcare Setting: Direct Costs and Incapacity Pay

    Jul 1, 2025, 00:00

  • MT8 Can Robotics Narrow the Access Disparities in Minimally Invasive Surgery?

    Jul 1, 2025, 00:00

  • PT2 Survival Analysis in Breast Cancer Patients Treated with Targeted Therapies and Conventional Therapies in the US: A Comparative Real World Study

    Jul 1, 2025, 00:00

  • MSR117 Estimation of Utilities for Patients with Metastatic Breast Cancer Using Vignette in Japan

    Jul 1, 2025, 00:00

  • EPH40 Association between Exposure to GLP-1 Treatment and Pancreatitis Risk in Obesity Patients: A Retrospective Database Study

    Jul 1, 2025, 00:00

  • EPH21 Socioeconomic Evaluation of Breast Cancer Attributable to Benzo[a]pyrene (BaP), Nitrogen Dioxide (NO2), and Polychlorinated Biphenyls 153 (PCB-153) Air Pollutants

    Jul 1, 2025, 00:00

  • EE292 Evaluating the Value of Over-the-Counter Oseltamivir for Influenza: A Cost-Utility Analysis From U.S. Payer and Societal Perspectives

    Jul 1, 2025, 00:00

  • PCR15 Psychosocial Distress and Quality of Life Among Minority Men Diagnosed with Prostate Cancer: A Systematic Review

    Jul 1, 2025, 00:00

  • HPR22 Comparing Hospital Prices Paid by Commercial Insurance Plans at 340B vs. Non-340B Hospitals: Implications for Employers and Patients

    Jul 1, 2025, 00:00

  • EE519 Economic Evaluation of Healthcare Point Solutions Versus Standard Care to Supplement Benefit Plans for Behavioral Health Adults Patients Using Real-World Synthetic Data: A Doubly Robust Causal Analysis

    Jul 1, 2025, 00:00

  • EE409 A Systematic Literature Review of Health Economic Models Structures for Chronic Rhinosinusitis with Nasal Polyps

    Jul 1, 2025, 00:00

  • MSR7 Transforming Regulatory Intelligence With AI Driven Methodologies in HEOR

    Jul 1, 2025, 00:00

  • EPH32 Is there a GLP-1 Halo Effect? Potentially Better Overall Health Management Due to Starting GLP-1 for Weight Loss

    Jul 1, 2025, 00:00

  • EE515 Measuring the Spillover Effect of Cancer on Family Members' Health: A US-Based Empirical Analysis

    Jul 1, 2025, 00:00

  • CO7 Progression From Systemic Lupus Erythematosus to Lupus Nephritis: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • HSD92 Use of Novel Therapies for Multiple Myeloma in the United States: Important Differences in Patient Characteristics, Access to Care, and Real-World Treatment Challenges

    Jul 1, 2025, 00:00

  • EE277 Real-World Telehealth Utilization and Healthcare Costs in Commercially Insured Women With Breast Cancer: A Claims-Based Study

    Jul 1, 2025, 00:00

  • EE347 Updated 1-Year Fracture Incidence and Costs of Fragility Fractures in US Post-Fracture Patients Based on Commercial Claims Databases

    Jul 1, 2025, 00:00

  • HPR9 From Data to Actionable Insight: A Collaborative Monitoring E) Initiative Convened by Canada’s Drug Agency (CDA-AMC) - Piloting Plans for Diabetes and Contraception

    Jul 1, 2025, 00:00

  • MSR100 Can Gen-AI Assist in Translating Health Economic Data Across Formats? A Proof-of-Concept for an HEOR Translator Tool

    Jul 1, 2025, 00:00

  • HSD60 Impact of Pharmacist Managed Pulmonary Arterial Hypertension Program on TYVASO Adherence

    Jul 1, 2025, 00:00

  • MSR62 Keeping With the Times: Emerging Methods for More Precise Survival Estimates to Inform Cost-Effectiveness Analysis

    Jul 1, 2025, 00:00

  • EE427 Real-World Long-Term Clinical and Economic Outcomes of Preterm Infants with Neonatal Respiratory Distress Syndrome in the United States

    Jul 1, 2025, 00:00

  • MSR118 Cognitive Impairment Detection through Recurrent Neural Networks and Mobile Health Technologies

    Jul 1, 2025, 00:00

  • HTA63 Trends in Use of Cost-Minimization Analyses in CDA-AMC Reimbursement Submissions

    Jul 1, 2025, 00:00

  • MT6 Improving Cancer Recurrence Detection using ctDNA Measures in Colorectal, Breast, and Non-small Cell Lung Cancers

    Jul 1, 2025, 00:00

  • RWD37 Identifying Treatment Patterns for Essential Thrombocythemia Using Real-world Data

    Jul 1, 2025, 00:00

  • EPH110 Trends in Vaccinations by Medicare Part D Beneficiaries

    Jul 1, 2025, 00:00

  • P35 Integrating Patient-Reported Outcomes in Clinical Care - Opportunities and Roadblocks From the Patient Perspective: A Scoping Review

    Jul 1, 2025, 00:00

  • PCR108 Assessing the Impact of Sociodemographic Factors on Patient Perceptions of Chronic Heart Failure Management

    Jul 1, 2025, 00:00

  • EE468 Cost-Effectiveness Analysis of Baricitinib Compared to Standard of Care in Improving Symptoms of Alopecia Areata for the Patients in the U.S. From the Healthcare Payer Perspective

    Jul 1, 2025, 00:00

  • EPH52 Protocol for a Real-World Retrospective Study on Chronic Obstructive Pulmonary Disease Outcomes Among Individuals Switching to Heated Tobacco Products Compared to Continued and Former Cigarette Smokers in Japan

    Jul 1, 2025, 00:00

  • EE260 A Real-World Analysis of Patient Cost Burden From COPD and Its Treatment Regimens

    Jul 1, 2025, 00:00

  • HSD57 Highly Effective Use of a Medical Affairs Team with Medical Science Liaison-delivered Education: The SMART-MSL Study

    Jul 1, 2025, 00:00

  • EPH183 Gender-Based Gaps In Access to Tricuspid Valve Interventions In England

    Jul 1, 2025, 00:00

  • EPH124 EHR Trends in First-Time ADHD Diagnoses and Amphetamine Prescriptions Across Age Groups (2021-2024)

    Jul 1, 2025, 00:00

  • EPH64 Trends and Disparities in Weight Loss Activities Among Adults With Prediabetes and Obesity in the United States: 2009-2020

    Jul 1, 2025, 00:00

  • PCR36 Enhancing Methods to Explore Meaningful Change in Patient Interviews: A Case Study in Spinocerebellar Ataxia (SCA)

    Jul 1, 2025, 00:00

  • EPH7 The Impact of Endoscopic Screening Programs for Gastric Cancer in Japan

    Jul 1, 2025, 00:00

  • MSR10 Real-time Predictions of Maternity Episode Expenses Using Machine Learning

    Jul 1, 2025, 00:00

  • RWD78 Psychotropic Medication Treatment Patterns in Employee Dependents with Autism Spectrum Disorder

    Jul 1, 2025, 00:00

  • P42 Transportability of Treatment Effect Measures for Binary Outcomes in Population-Adjusted Indirect Comparisons

    Jul 1, 2025, 00:00

  • MT29 Budget Impact Analysis of Continuous Glucose Monitoring with Predictive Alarms for Type 1 Diabetes in Chile (T1D): Perspective of the Explicit Health Guarantees Regime

    Jul 1, 2025, 00:00

  • HTA79 Annual Direct Medical Costs with Beta-Thalassemia in the Brazilian Public Healthcare System (SUS)

    Jul 1, 2025, 00:00

  • P30 Navigating Real-World Data (RWD) Complexities: Operational Assessment Strategy to Identify Fit-For-Purpose Data Sources for Real-World Evidence (RWE) Studies With Regulatory Purpose (OASIS)

    Jul 1, 2025, 00:00

  • P33 Introduction of Distress Thermometer (DT) Screening in the US Community Oncology Setting: A Retrospective Study of Electronic Health Records (EHR) Integration

    Jul 1, 2025, 00:00

  • HTA80 Consistency in Reimbursement Decisions for Pediatric Rare Disease Drugsat Canadian HTA Agencies: CDA Versus INESSS

    Jul 1, 2025, 00:00

  • MSR112 Can Multi-Cancer Early Detection Tests Reduce Cancer Mortality?

    Jul 1, 2025, 00:00

  • HSD112 Trends in Attainment of the Kidney Health Evaluation for Patients With Diabetes Measure Among Insured Individuals in the US, 2021-2024

    Jul 1, 2025, 00:00

  • RWD71 Health Care Resource Utilization (HCRU), and Direct Medical Costs Among Patients With Locally Advanced or Metastatic HER2 Negative Gastric Cancer (GC) in the United States

    Jul 1, 2025, 00:00

  • EE393 Cost-Effectiveness of Umeclidinium/Vilanterol Combination Therapy for Group B COPD Patients

    Jul 1, 2025, 00:00

  • PT1 Developing a Budget Impact R Shiney Application to Assess the Financial Implications of Implementing Organized Cancer Screening Programs in Countries with Limited Resources: Breast Cancer as an Example

    Jul 1, 2025, 00:00

  • RWD123 Pharmacovigilance Studies Using a Representative Sample From the French National Health Insurance Database (ESND): A Targeted Literature Review

    Jul 1, 2025, 00:00

  • PCR127 A Targeted Literature Review of Patient Perspectives of Placebo Use in Clinical Trials: How Can the Patient Voice Help Drug Developers in Trial Design, Recruitment, and Retention?

    Jul 1, 2025, 00:00

  • MSR121 An Evaluation of PhlexNeuron, an Internal, Proprietary Artificial Intelligence (AI) Tool for Systematic Literature Review (SLR) Screening

    Jul 1, 2025, 00:00

  • RWD91 A Retrospective Analysis of Real-World Data: Assessing and Predicting Cardiovascular Risk Associated with Calcium Channel Blockers in Patients with Hypertension

    Jul 1, 2025, 00:00

  • RWD29 A Retrospective Cohort Study Evaluating the Association Between Fibrosis-4 Index and Major Adverse Cardiovascular Events in Patients with Metabolic Dysfunction-Associated Steatohepatitis

    Jul 1, 2025, 00:00

  • EPH36 Global, Regional, and National Burdens of Type 1 and Type 2 Diabetes Mellitus in Adolescents from 1990 to 2021, with Forecasts to 2030: A Systematic Analysis of the Global Burden of Disease Study 2021

    Jul 1, 2025, 00:00

  • EPH51 Trends In Oral JAK Inhibitor And Other Drug Use For Myelofibrosis: A Retrospective Real-World Study

    Jul 1, 2025, 00:00

  • EE227 Medical Costs in Patients with Pulmonary Arterial Hypertension (PAH) on Oral Triple Therapy including Selexipag in the United States (US): A retrospective Claims-Based Study

    Jul 1, 2025, 00:00

  • PCR88 Patient Attitudes and Emotions Predict Health Outcomes: Evidence From the National Health and Wellness Survey

    Jul 1, 2025, 00:00

  • HTA69 A Retrospective Analysis of the Italian Medicines Agency’s Evaluation of Real-World Evidence in Innovativeness Assessments

    Jul 1, 2025, 00:00

  • CO29 Medication Utilization Post Selective Laser Trabeculoplasty or Minimally Invasive Glaucoma Surgeries in Patients With Open-Angle Glaucoma or Ocular Hypertension: A Systematic Review of Recent Literature

    Jul 1, 2025, 00:00

  • MSR29 Reviewing Current Trends Regarding Use of Artificial Intelligence in Generating Real-World Evidence From Patient Medical Charts

    Jul 1, 2025, 00:00

  • EE225 Cost Effectiveness Analysis of a Pharmacist-Led Clinical Decision Support System Powered by Machine Learning to Reduce Drug-Associated Acute Kidney Injury in the Adult Non-ICU Setting

    Jul 1, 2025, 00:00

  • HSD29 National Assessment of Prostate and Colon Cancer Screening Using National Health Interview Survey (NHIS)

    Jul 1, 2025, 00:00

  • MSR93 DAGDraw: A Responsive and Modern Directed Acyclic Graph Drawing Tool for Causal Inference and Transportability Analysis

    Jul 1, 2025, 00:00

  • The Role of Mental Health in Healthcare Choices: A Discrete Choice Experiment Examining Preferences for Primary Care

    Jul 1, 2025, 00:00

  • HPR28 Interventions To Overcome the Challenges for Identifying Substandard, Spurious, Falsely Labeled, Falsified and Counterfeit Drugs (SSFFC). A Systematic Review

    Jul 1, 2025, 00:00

  • EPH144 Disease and Economic Burden of Dengue in Colombia, 2018-2022

    Jul 1, 2025, 00:00

  • RWD167 Inpatient Hospitalization Trends for COPD in 2018 versus 2021 in United States: A Retrospective Analysis

    Jul 1, 2025, 00:00

  • EPH147 Distribution, Inequalities and Associated Factors of Unmet Medical Needs Among Older Adults: Evidence From The National Health Service Survey

    Jul 1, 2025, 00:00

  • PCR107 Differential Item Functioning With the National Eye Institute Visual Function Questionnaire-25 in Patients With Vitreomacular Traction

    Jul 1, 2025, 00:00

  • PT9 Application of ML-NMR to Time-to-Event Outcomes Using Parametric Models and Flexible Parametric (Spline) Models: A Case Study Using A Simulated Dataset

    Jul 1, 2025, 00:00

  • EPH33 Tinnitus Risk After XBB.1.5 COVID-19 Vaccination: A Self-Controlled Case Series Study

    Jul 1, 2025, 00:00

  • P24 AI Tools for Literature Reviews: Are Current Guidelines Meeting the Needs of Researchers?

    Jul 1, 2025, 00:00

  • PCR5 Perspectives of Adult Patients and Caregivers on the Management and Challenges Associated With Neurofibromatosis Type 1 and Plexiform Neurofibroma: A Multinational, Qualitative Study

    Jul 1, 2025, 00:00

  • EE483 Efficiency Benefits and Practice Value of Alcon's Digital Cataract Surgery Planning System

    Jul 1, 2025, 00:00

  • PCR167 Hypertension Medication Use and Primary Medication Non-Adherence Among Postpartum Women

    Jul 1, 2025, 00:00

  • PCR164 Development and Validation of the Symptom Assessment for Bronchiectasis (SABRE) for the FDA Qualification Program: A Novel Patient-Reported Outcome Instrument to Measure Symptoms of Non-Cystic Fibrosis Bronchiectasis

    Jul 1, 2025, 00:00

  • RWD66 Utilizing Generative AI to Automate Model Selection and Network Meta-Analyses

    Jul 1, 2025, 00:00

  • CO54 Systematic Literature Review and Network Meta-Analysis of Crovalimab Compared With Eculizumab, Ravulizumab and Best Supportive Care in Paroxysmal Nocturnal Hemoglobinuria

    Jul 1, 2025, 00:00

  • RWD35 Real-World Impact Of Recurrence On Overall Survival (OS) In Patients With Unresectable Locally Advanced (LA) Esophageal/Gastroesophageal Junction Cancer (EC/GEJC) Treated With Definitive Chemoradiotherapy (dCRT) In US Community Oncolo ...

    Jul 1, 2025, 00:00

  • EE504 Characterizing the Burden and Drivers of Healthcare Utilization and Spending for Epilepsy and Seizures in the U.S., 2016-2022

    Jul 1, 2025, 00:00

  • PCR94 Use of Diaries to Capture Patient-Reported Outcomes in FDA New Drug Approvals (2019-2023)

    Jul 1, 2025, 00:00

  • CO21 Real-World Evidence on Clinical Outcomes and Safety of Trastuzumab Biosimilar in Colombian Breast Cancer Patients

    Jul 1, 2025, 00:00

  • PCR91 Patient Reported Outcomes in BRUIN CLL-321: A Phase 3 Trial of Pirtobrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

    Jul 1, 2025, 00:00

  • RWD134 Follow Me, If You Can: How Tokenized Linkage Extends Patient Observations in Real-World Databases - the Komodo Research Dataset Example

    Jul 1, 2025, 00:00

  • PT17 Challenges for PAIC in Rare Diseases: Results of a Systematic Literature Review

    Jul 1, 2025, 00:00

  • MT40 Prospective, Comparative Study Between Fully-Automated and Semi-Automated Whole Blood Processing Systems in a Colombian Blood Bank Center

    Jul 1, 2025, 00:00

  • EE513 Assessing the Economic Impact of Biosimilars in the U.S.: A cost analysis of Infliximab, Trastuzumab, and Rituximab

    Jul 1, 2025, 00:00

  • HSD50 Racial/Ethnic Disparities in Veterans' Healthcare Experiences Across VA and Non-VA Settings: An Analysis of the Medical Expenditure Panel Survey (2018-2019)

    Jul 1, 2025, 00:00

  • HTA84 Payer Perceptions on Creating a National Value assessment Body in the US

    Jul 1, 2025, 00:00

  • EE271 30-Day All-Cause Readmission Outcomes Among Kidney Transplant Recipients with vs. without Autosomal Dominant Polycystic Kidney Disease

    Jul 1, 2025, 00:00

  • EE443 Costs Avoided by the Inclusion of Finerenone Based on Hospitalization and Death Due to Cardiovascular Events and the Progression of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D) in Colombia

    Jul 1, 2025, 00:00

  • HTA11 A Standardized Framework for the Acceptance of Non-Randomized Evidence From Real-World Data in HTA: Insights From EU Guidelines and National Practices

    Jul 1, 2025, 00:00

  • RWD156 Validation of Real-World Recurrence-Free Survival (rwRFS) and Distant Metastasis-Free Survival(rwDMFS) Endpoints in Early-Stage Melanoma

    Jul 1, 2025, 00:00

  • RWD128 Device Longevity and Survival After Cardiac Resynchronization Therapy Pacemaker (CRT-P) Implantation in the Brazilian Public Health System (SUS): 12-Year Real-World Data Analysis

    Jul 1, 2025, 00:00

  • EE324 Cost Analysis of Surgical Treatment for Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Refractory to Clinical Therapy in Brazil

    Jul 1, 2025, 00:00

  • MSR114 Exploring the Impact of Data Availability on Time-Course Model-Based Network Meta-Analysis

    Jul 1, 2025, 00:00

  • HTA19 The Impact of Meeting Orphan Criteria on Reimbursement Decisions and ICERs in Scotland

    Jul 1, 2025, 00:00

  • HPR140 The Importance of Medicare Advantage Plan Design and Impact on Health Equity

    Jul 1, 2025, 00:00

  • RWD151 Real-World Evidence on the Use of Secondary Prevention for People With ASCVD or CKD: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • PCR84 Health Utility Values of Canadian Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer

    Jul 1, 2025, 00:00

  • MSR80 Evaluation of Marginal Healthcare Expenditures and Health-related Quality of Life in Multiple Sclerosis with a Bayesian Quantile Machine Learning Approach

    Jul 1, 2025, 00:00

  • HPR25 Artificial Intelligence Software as a Medical Devi Regulatory Approvals and Post-Deployment Evaluation Frameworks in North America and Europe

    Jul 1, 2025, 00:00

  • PCR93 Beyond Clinical Data: Assessing Usage Patterns of Real-World Home-Reported Outcomes To Capture the Full Burden of Atopic Dermatitis Symptoms and Flares

    Jul 1, 2025, 00:00

  • HTA92 Diffusion and Launch Sequencing of Cell and Gene Therapies across the USA, Europe, Canada and Australia

    Jul 1, 2025, 00:00

  • MSR61 Psychometric Validation of the Sunlight Exposure Diary and Erythropoietic Protoporphyria Impact Questionnaire (EPIQ) Using Data from the AURORA Clinical Study in Erythropoietic Protoporphyria (EPP)

    Jul 1, 2025, 00:00

  • PCR193 Treatment Experience and Other Health and Social Characteristics Among Patients With Cancer From a Large US Population-Based Survey

    Jul 1, 2025, 00:00

  • P27 Use of Metamodels in Health Economics to Bypass Complexity and Democratize Modeling

    Jul 1, 2025, 00:00

  • PCR180 Healthcare Burden Among Patients with Graves Disease: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • MSR119 Assessing the Impact of PD-L1 and BRAF Biomarkers on Long-Term Survivorship (LTS) Rates Among Treatment-Naive Advanced Melanoma Patients Receiving Immune Checkpoint Inhibitors (ICIs)

    Jul 1, 2025, 00:00

  • EE441 Daily Intravenous Ketamine for Treatment-Resistant Depression: a Cost-Effectiveness Analysis Alongside the Clinical Trail

    Jul 1, 2025, 00:00

  • EE232 Economic Burden of Chronic Kidney Disease (CKD) in Type 2 Diabetes (T2D), Considering the Costs of Hospitalization Due to Heart Failure (HF) in Colombia

    Jul 1, 2025, 00:00

  • RWD89 Leveraging Consumer-Grade Wearables in Clinical Trials: Insights From Digital Primary Endpoints

    Jul 1, 2025, 00:00

  • PCR34 More than "financial toxicity": the Socioeconomic Impact of Cancer and Cancer Care on Patients and Their Relatives

    Jul 1, 2025, 00:00

  • CO24 Systematic Literature Reviews (SLRs) Of Clinical Outcomes And Patient-Reported Outcomes Of Recommended Treatments For Patients With Platinum-Resistant Ovarian Cancer (PROC)

    Jul 1, 2025, 00:00

  • PCR17 Estimating the Impact of Pill Burden on the Utility of Patients Undergoing Hemodialysis

    Jul 1, 2025, 00:00

  • HTA23 Broadening the Evidence Base: Incorporating Environmental Considerations Into HTAs

    Jul 1, 2025, 00:00

  • EPH113 Characteristics of Patients Initiating Wegovy (Semaglutide) for Cardiovascular Risk Reduction in a Medicare Population

    Jul 1, 2025, 00:00

  • EE416 Molecular Profiling, Treatment (Tx) Patterns, and Healthcare Resource Utilization (HCRU) in United States Patients with Unresectable Locally Advanced/Metastatic Biliary Tract Cancer

    Jul 1, 2025, 00:00

  • HPR89 What Non-Profit Development of Pretomanid Can Teach About Paths to Innovation and Global Access to Treatments for Diseases of Poverty?

    Jul 1, 2025, 00:00

  • HSD72 Virtual Cancer Screening and Support Program: A Model for Improving Cancer Care Continuity Through Screening, Diagnosis, Treatment, and Survivorship

    Jul 1, 2025, 00:00

  • HTA70 A Review of NICE UK Submissions for Antibody-Drug Conjugates in Oncology

    Jul 1, 2025, 00:00

  • PCR79 Assessing Quality-of-Life Outcomes in Ulcerative Colitis: A Review of Canadian HTA Submissions

    Jul 1, 2025, 00:00

  • PCR76 Do Existing Caregiver Assessments Measure What's Important to Caregivers?

    Jul 1, 2025, 00:00

  • HPR48 Why It Is Still Important to Ensure the Price is Right: Updates to Access Restrictions for Therapies Treating Duchenne Muscular Dystrophy

    Jul 1, 2025, 00:00

  • HPR26 Are Existing Descriptions of Unmet Medical Need Fit for Purpose in the CMS Drug Negotiation Program Context?

    Jul 1, 2025, 00:00

  • EE355 Healthcare Resource Utilization in the Management of Patients with Relapse/Refractory Mantle Cell Lymphoma in Canada

    Jul 1, 2025, 00:00

  • PCR224 Examination of Different Segments of Health Literacy and Health Awareness Among Pregnant Women

    Jul 1, 2025, 00:00

  • PCR222 Characterizing Improvements in Physical Functioning with PROMIS-PF and In-Trial Exit Interviews: A Mixed-Methods Analysis to Understand the Meaningful Changes Experienced by TGCT Patients on Vimseltinib in the MOTION Trial

    Jul 1, 2025, 00:00

  • EE275 Economic Evaluation of Adjuvant Chemotherapy for Soft Tissue Sarcoma Using Linked NETSARC+ (French Registry) and SNDS (French National Health Data System) Real World Data: The Deepsarc Study

    Jul 1, 2025, 00:00

  • HSD56 Bridging Racial Disparities in Aspirin Therapy for Preeclampsia Prevention Using Virtual Maternity Care

    Jul 1, 2025, 00:00

  • CO14 Characteristics of Patients With Bullous Pemphigoid in the US Medicare Population

    Jul 1, 2025, 00:00

  • RWD130 Real-World Adverse Event Profile of Glucagon-Like Peptide-1 Receptor Agonists in Overweight and Obese US Adults

    Jul 1, 2025, 00:00

  • PCR227 Mapping the NEI-VFQ-25 to the EQ-5D-Y-3L and CHU-9D among High School Students with Myopia in China

    Jul 1, 2025, 00:00

  • PCR73 Discontinuation of Disease-Modifying Therapies in Older Adults with Multiple Sclerosis

    Jul 1, 2025, 00:00

  • EE500 Cost-Utility Analysis of Dupilumab Versus Omalizumab in the Treatment of Severe Asthma in China

    Jul 1, 2025, 00:00

  • PCR60 Exploring Patterns of App-Based Tracking of Real-World Symptom and Treatment Experiences in Patients with Sickle Cell Disease and Cystic Fibrosis

    Jul 1, 2025, 00:00

  • EE335 Economic Burden of Hwabyeong in South Korea: An Analysis of Direct, Non-Medical, and Indirect Costs

    Jul 1, 2025, 00:00

  • HSD67 Heterogeneity in Preferences for HIV Self-Testing Among Ugandan Men

    Jul 1, 2025, 00:00

  • HSD53 The COM-IC Project: Recommendations for Core Outcome Measurement To Improve (Routine Dementia) Care Quality in Australian Aged Care Settings

    Jul 1, 2025, 00:00

  • HPR45 The Cost of 340B to States

    Jul 1, 2025, 00:00

  • EPH158 National Assessment of Depression Between Early vs Late Adolescents Using National Survey of Child Health Survey

    Jul 1, 2025, 00:00

  • PCR47 Social Listening: A Content Analysis of Social Media Discussions in Prader Willi Syndrome (PWS)

    Jul 1, 2025, 00:00

  • EE290 Potential Impact of New Strategies of Infant Immunization in the Disease and Economic burden of RSV in Colombia

    Jul 1, 2025, 00:00

  • HPR116 Characterizing Social Determinants of Health in the Population Receiving Pneumococcal Vaccine in a National Pharmacy Chain in the United States

    Jul 1, 2025, 00:00

  • HSD98 Bariatric Surgery Costs in Chile: Cost of a Comprehensive, Evidence-Based, and High-Quality of Care Program

    Jul 1, 2025, 00:00

  • EE237 Real-World Treatment Patterns, Healthcare Costs and Resource Utilization in First-Line Treatment of Metastatic NSCLC in the US using MarketScan® data

    Jul 1, 2025, 00:00

  • RWD48 Impact of Circulating Tumor DNA (ctDNA) Burden Among Patients with Head and Neck Dquamous Cell Carcinoma (HNSCC) - A RWE Analysis

    Jul 1, 2025, 00:00

  • PCR169 Impact of Primary Care Subsidies on Healthcare Utilization: Evidence From Singapore's Merdeka Generation Package

    Jul 1, 2025, 00:00

  • RWD1 Hemoglobin Levels and Social Determinants of Health as Risk-factors of End-Organ Damage in Sickle Cell Disease: A Retrospective Analysis

    Jul 1, 2025, 00:00

  • EE320 Impact of Diagnosis Delay on Healthcare Resource Utilization (HCRU) among Patients with Pulmonary Arterial Hypertension (PAH)

    Jul 1, 2025, 00:00

  • HTA1 Pathways to MBS Funding for In-Vitro Diagnostics: Timelines and Success Rates in Australia

    Jul 1, 2025, 00:00

  • HTA60 Impact of a Digital Musculoskeletal Program on Healthcare Spending Among Participants with Chronic Musculoskeletal Pain and Comorbidities

    Jul 1, 2025, 00:00

  • EE430 Medicare Cost Comparison of Transcarotid Artery Revascularization (TCAR) Versus Transfemoral Carotid Artery Stenting (TF-CAS)

    Jul 1, 2025, 00:00

  • EE403 Estimating the Family Spillover Effects of Cardiovascular Diseases: Evidence from the Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • CO50 Analysis of Patient-Reported Outcomes of MCO-010 Mutation Agnostic Optogenetic Therapy for Retinitis Pigmento 12-Month Results from a Phase 2b Randomized, Sham-Controlled, Patient- and Assessor-Masked Clinical Trial (RESTORE)

    Jul 1, 2025, 00:00

  • EPH99 Assessment of Real-World Adverse Events Associated with Ozanimod in Relapsing Remitting Multiple Sclerosis (RRMS)

    Jul 1, 2025, 00:00

  • P53 Alignment Between CDA Recommendations and pCPA Negotiation Outcomes: Exploring Factors Influencing Reimbursement Success

    Jul 1, 2025, 00:00

  • EE349 Costs of Type 1 Diabetes Acute and Chronic Complications in Brazil Private Healthcare System

    Jul 1, 2025, 00:00

  • EE360 Short-Term (180-Day) Health Care Costs for Patients With Commercial or Medicare Advantage (MA) Insurance Initiating Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy for Diabetes

    Jul 1, 2025, 00:00

  • MSR2 Developing a Feature Selection Workflow for Variable-Rich Data: A Case Study Utilizing Claims Data to Build Classifiers for the Prediction of Opioid Use Disorder Among Persons Authorized to Purchase Medical Cannabis

    Jul 1, 2025, 00:00

  • EPH123 An Epidemiological Assessment of the Stroke Burden in Hungary Using Data From the Global Burden of Disease Study (1990–2021)

    Jul 1, 2025, 00:00

  • HTA55 Effectiveness of Cell-Free Tumor DNA Tests in Early Lung Cancer Detection

    Jul 1, 2025, 00:00

  • EE365 Real-World Healthcare Resource Utilization and Economic Burden Associated With Progressive Pulmonary Fibrosis in Commercially Insured and Medicare Advantage Populations in the United States

    Jul 1, 2025, 00:00

  • EE476 Cost-Effectiveness of Pegfilgrastim Versus 5-day Filgrastim in Early Breast Cancer Patients Undergoing Neoadjuvant and Adjuvant Chemotherapy: A Trial-Based Economic Evaluation

    Jul 1, 2025, 00:00

  • RWD70 Barriers to Genetic Risk Factor Molecular Testing in CLL: An Analysis of Real-World Practice and Alignment with 2023 Guidelines in Germany

    Jul 1, 2025, 00:00

  • HPR158 Is the Biologics Price Competition and Innovation Act Working as Intended?

    Jul 1, 2025, 00:00

  • RWD16 Leveraging CMS Medicare Data for Oncology RWE: Benefits, Limitations, and Opportunities, and Insights into Enrollment Patterns

    Jul 1, 2025, 00:00

  • EE447 Integrating Dynamic Pricing Into Cost-Effectiveness Models: Implications for US-Based Drug Evaluations

    Jul 1, 2025, 00:00

  • EPH126 Identify the Adverse Drug Reactions Among Rheumatoid Arthritis Patients Being Administered Specific Classes of Disease-Modified Anti-Rheumatic Drugs (DMARDs)

    Jul 1, 2025, 00:00

  • EPH122 First-Trimester Antiepileptic Drug Exposure and Adverse Pregnancy Outcomes: Insights from a Cohort Study in the US

    Jul 1, 2025, 00:00

  • EPH87 Influence of Overweight and Obesity on Disease Progression, Healthcare Utilization and Costs Among People With Prediabetes: A Cohort Study in China

    Jul 1, 2025, 00:00

  • MT3 Clinical and Economic Benefits of Branched Endovascular Stent Grafting for Intact Thoracoabdominal Aortic Aneurysm Repair: A Real-World Data Analysis

    Jul 1, 2025, 00:00

  • HPR125 Increasing Recognition Towards Inclusion of Patient Preferences in Healthcare Intervention Development and Access- Current Landscape and Way Forward

    Jul 1, 2025, 00:00

  • HPR138 2025 Review of Gene Therapy Access Landscape

    Jul 1, 2025, 00:00

  • EE246 Estimating the Burden of Illness and Healthcare Costs Among Incident Catheter Users: A Comparison of Intermittent and Indwelling Catheter Cohorts Across Spinal Cord Injury, Multiple Sclerosis, Spina Bifida, and Benign Prostatic Hyperp ...

    Jul 1, 2025, 00:00

  • RWD39 Examining Patterns in Breast Cancer Patient Characteristics and Treatment Throughout the COVID-19 Pandemic

    Jul 1, 2025, 00:00

  • EE451 Assessing the Operational Efficiency of a Vial Filling Robot in an Outpatient or a Community Pharmacy

    Jul 1, 2025, 00:00

  • HPR5 Insight into Approvals, Marketing, and Pricing of New Medicines 2018 to 2022

    Jul 1, 2025, 00:00

  • MSR116 Trends in Current Smoker Profiles Among US Adults From 2019-2024: An Unsupervised Clustering Analysis

    Jul 1, 2025, 00:00

  • EE243 Cost of Hypertension Cardiovascular and Renal Complications in Private Healthcare System in Brazil

    Jul 1, 2025, 00:00

  • HPR153 The Reimbursement Status of Ustekinumab Across HTAs: A Global Perspective

    Jul 1, 2025, 00:00

  • EPH172 Exploring Pregnancy-Related Coding Practices in Administrative Claims Data: Insights for Health Outcomes Researchers

    Jul 1, 2025, 00:00

  • MT28 Harnessing Digital Measures of Physical Function in Neurological Conditions: Findings From a Targeted Literature Review

    Jul 1, 2025, 00:00

  • RWD165 Pioneering the Integration of Health-Equity Variables Into an Administrative Claims Database: A Step Forward in the Journey to Supporting Underserved Populations

    Jul 1, 2025, 00:00

  • HPR127 Evolution of Technology Diffusion Within Brazilian Universal Healthcare System (Sistema Único De Saúde – SUS) 2+ Years After Listing of Antiangiogenics Treatment for Diabetic Macular Edema (DME)

    Jul 1, 2025, 00:00

  • RWD100 Assessing the Proportion of Days Covered within 180 Days after First Medication Fills Among Bipolar Disorder Patients Using Real-World Data

    Jul 1, 2025, 00:00

  • PCR179 Patient's Experience of Crohn's Disease: A Conceptual Model Based on Qualitative Interviews

    Jul 1, 2025, 00:00

  • HPR56 Does the 340B Program Encourage and Reward Non-Profit Hospital Consolidation?

    Jul 1, 2025, 00:00

  • PCR85 The Socioeconomic Impact of Cancer and Cancer Care on Patients and Their Relatives: Assessing the Content Validity of Dedicated Patient-Reported Outcomes Measurement (PROM) Instruments

    Jul 1, 2025, 00:00

  • EE254 Budget Impact Analysis of Revumenib for the Treatment of Relapsed or Refractory Acute Leukemias With a KMT2A Translocation in the United States

    Jul 1, 2025, 00:00

  • MSR39 Large Language Model and Contextual Prioritization of Titles and Abstracts for Systematic Review Screening

    Jul 1, 2025, 00:00

  • PCR64 Enhancing Early-Phase Trial Outcomes: The Value of Patient-Reported Treatment Tolerability

    Jul 1, 2025, 00:00

  • PCR190 Impact of Valbenazine on Improvements in Disability and Functional Impairment in Patients With Tardive Dyskinesia (TD): Sheehan Disability Scale (SDS) Results From a Phase 4 Randomized Withdrawal Study (NCT03891862)

    Jul 1, 2025, 00:00

  • EE341 Economic Burden of Prader-Willi Syndrome Among Pediatric Patients in the United States

    Jul 1, 2025, 00:00

  • EE356 Cost-Effectiveness of Population-Based Risk Assessment and Hereditary Cancer Genetic Testing in Primary Care

    Jul 1, 2025, 00:00

  • EPH135 Sex-Stratified Differences in Cardiac Interventions, Complications and Outcomes in the Netherlands Between 2018 and 2023

    Jul 1, 2025, 00:00

  • P50 Quantifying Treatment Value Using Alternative Health Benefit Metrics: A Case Study of Adjuvant Osimertinib for Elderly Patients with EGFR mutated NSCLC Following Resection

    Jul 1, 2025, 00:00

  • MT22 Hope as a Catalyst: AI-Based Conversational Agents in Mental Health Support

    Jul 1, 2025, 00:00

  • HPR146 Real-World BReast CAncer gene 1 (BRCA1) and BReast CAncer gene 2 (BRCA2) Testing Trends by Race for Patients with Metastatic Prostate Cancer (mPC) from 2015 to 2024 in the Community Oncology Setting in the United States (US)

    Jul 1, 2025, 00:00

  • PCR151 Relationship Between Patient Engagement and Weight Management in a Pharmacist-led Clinic within a Managed Care Organization

    Jul 1, 2025, 00:00

  • PCR61 Exploring the Health and Well-being of Pediatric Caregivers within Chinese Cultural Contexts: A Systematic Review of Qualitative Studies from Chinese Databases

    Jul 1, 2025, 00:00

  • EPH129 Evaluation of Availability, Prices, and Affordability of Medicines for Hepatitis B and Hepatitis C Viruses at Community Pharmacies in a Senatorial District in North-Central Nigeria

    Jul 1, 2025, 00:00

  • MSR18 Machine Learning Prediction of 3-Year Mortality in Patients Undergoing Percutaneous Coronary Intervention for Coronary Artery Disease

    Jul 1, 2025, 00:00

  • EPH119 Chronic Conditions Significantly Increase Risk of Severe RSV Outcomes in Medicaid Beneficiaries Aged 18-59 Years: A Claims Data Analysis

    Jul 1, 2025, 00:00

  • RWD172 Implementation of New Real-World Data Quality Frameworks and Initiatives to Address Challenges in Oncology Electronic Health Record (EHR)-Derived Databases for Research

    Jul 1, 2025, 00:00

  • MSR124 Impact of NICE Severity Modifiers on Willingness-to-Pay Thresholds

    Jul 1, 2025, 00:00

  • EE209 Non-Invasive Tests (NITs) to Risk-Stratify Patients with Noncirrhotic Metabolic-Associated Steatohepatitis (MASH) in a Specialty Setting Eligible for Resmetirom: A Cost-Effectiveness Analysis from a U.S. Payer Perspective

    Jul 1, 2025, 00:00

  • EE297 Budget Analysis of the Implementation of Biosimilars in a Large Private Health Insurance Company in Southern Brazil

    Jul 1, 2025, 00:00

  • HTA42 Better Off Dead: Mitigating For Situations Where Improving Survival Isn't Cost-Effective

    Jul 1, 2025, 00:00

  • EE524 Millions in Annual National Savings Could Be Realized From Improving the Quality of Uterotonic Medications in Sub-Saharan Africa

    Jul 1, 2025, 00:00

  • HPR105 Evaluation of the Cost of Treatment on Endometriosis in the Hungarian Public-Funded Healthcare System

    Jul 1, 2025, 00:00

  • HPR134 Hepatitis C Elimination via Subscription-Based Payment Models: A Synthetic Control Study from Washington and Louisiana

    Jul 1, 2025, 00:00

  • PCR194 Qualitative Evaluation of a Tool for Collecting Stated and Revealed Patient Preferences in the Context of Atypical Antipsychotics for the Treatment of Depression or Bipolar Disorder in Adults

    Jul 1, 2025, 00:00

  • EE319 Economic Burden of Opioid-Induced Constipation Among Patients With or Without Cancer in the United States

    Jul 1, 2025, 00:00

  • EPH75 Development and Validation of a Machine Learning-based screening Algorithm to Predict High Risk of Hepatitis C Infection

    Jul 1, 2025, 00:00

  • PCR78 Approaches to Decreasing Emotional Burden during Qualitative Interviews to Improve Data Quality and Participant Engagement

    Jul 1, 2025, 00:00

  • EE224 Evaluating Attributes of Non-Oncology Orphan Approvals From 2015-2024

    Jul 1, 2025, 00:00

  • EE265 Key Clinical Drivers of the Long-Term Cost-Effectiveness of Semaglutide1mg for the Treatment of People With Type 2 Diabetes and Cronic Kidney Disease Based on the FLOW Clinical Trial

    Jul 1, 2025, 00:00

  • EE420 Compare the Return on Investment of Pulsed Field Ablation With Conventional Thermal Ablation for Treatment of Atrial Fibrillation in China

    Jul 1, 2025, 00:00

  • HPR170 Private Insurance May Fail to Protect Against Healthcare Financial Hardship, Evidence from the 2018 and 2019 Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • CO11 Comparative Analysis of Robotic-Assisted, Laparoscopic, and Open Radical Nephrectomy: Trends, Costs, and Clinical Outcomes

    Jul 1, 2025, 00:00

  • EE467 Acute Myocardial Infarction and Associated Healthcare Resource Utilization and Costs Among U.S. Patients With Extreme High Versus Low Lipoprotein (a)

    Jul 1, 2025, 00:00

  • EPH84 Epidemiological Insights in Cornelia-de-Lange Syndrome: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • PCR81 Physician-Reported Satisfaction with, Challenges in, and Patient Adherence to, Immunosuppressive Treatment among Kidney Transplant Recipients: Results From a Real-World Survey

    Jul 1, 2025, 00:00

  • P52 A Policy Framework for Multi-Indication Evidence Synthesis in Oncology Health Technology Assessment (HTA)

    Jul 1, 2025, 00:00

  • MT18 Impact of Single-Patient Use Electrocardiogram Monitoring in the Cost of Care and Infection Prevention of CABG Surgery Patients in Canada

    Jul 1, 2025, 00:00

  • SA13 An Assessment of Financial Burden and its Association with Desmoid Tumor Specific Symptoms and Impacts in Adult Desmoid Tumor Patients: Desmoid Tumor Research Foundation Natural History Study

    Jul 1, 2025, 00:00

  • PT18 Prescribing Trends of Disease-Modifying Medications in Texas Medicaid Enrollees with Sickle Cell Disease

    Jul 1, 2025, 00:00

  • CO37 A Clinical Prediction Model of Asymptomatic Left Ventricular Dysfunction in Survivors of Childhood Cancer in Ontario, Canada

    Jul 1, 2025, 00:00

  • EPH89 What Are the Characteristics Associated With Frequent Physical Exercise Among Adults With Arthritis? Results of a National Survey in the United States

    Jul 1, 2025, 00:00

  • HSD100 Enhanced Outcomes and Reduced Healthcare Utilization with Specialized Home Healthcare Service Providers for Ostomy and Urological Patients: Comparative Research with Pharmacy-Based Care

    Jul 1, 2025, 00:00

  • EE528 Treatment Patterns, Healthcare Resource Utilization, and Healthcare Costs Among Patients with Metastatic Gastric/Gastroesophageal Junction Cancer in Commercially Insured Patients in the United States

    Jul 1, 2025, 00:00

  • MSR90 From Bias to Confiden Exploring Quantitative Bias Analysis’ (QBA’s) Role in Matching Adjusted Indirect Treatment Comparison

    Jul 1, 2025, 00:00

  • EE517 Willingness to Pay for a Quality Adjusted Life Year Across Different Time Horizons: Direct Elicitation in Quebec

    Jul 1, 2025, 00:00

  • HSD24 Patient Characteristics Associated with the Use of Newly Approved Disease-Modifying Therapy (DMT) for Sickle Cell Disease in Texas Medicaid

    Jul 1, 2025, 00:00

  • RWD22 Development and Validation of a Claims-Based Approach to Identify Patients with Metastatic HR+ HER2- Breast Cancer

    Jul 1, 2025, 00:00

  • RWD111 Unmet Need in CIDP Patients Treated With Immunoglobin: Results of a Multinational Real-World Survey

    Jul 1, 2025, 00:00

  • CO18 Assessing the Comorbidity Burden of Ehlers-Danlos Syndromes (EDS): An Analysis Using US Real-World Data

    Jul 1, 2025, 00:00

  • EE431 Healthcare Costs and Resource Use in Patients With Sjögren's Syndrome (SS): A Systematic Literature Review of Real-World Evidence (RWE) Studies

    Jul 1, 2025, 00:00

  • PCR166 Tremor Symptoms and Associated Activities of Daily Living Impacts in Essential Tremor: A Qualitative Concept Elicitation and Mapping Study

    Jul 1, 2025, 00:00

  • HPR142 The Evolution of Value-Based Agreements in US Healthcare: Barriers, Opportunities, and Future Prospects

    Jul 1, 2025, 00:00

  • PT13 Clinician-Reported Outcomes—A Rare Opportunity for Orphan Labels?

    Jul 1, 2025, 00:00

  • HPR107 Trends in Breast Cancer Drugs Approved by the US Food and Drug Administration, 1980-2024

    Jul 1, 2025, 00:00

  • PT10 Patient-Reported Outcome Endpoint Emulation in Heart Failure External Control Arm Study (EMULATE-HF PRO-ECA Study)

    Jul 1, 2025, 00:00

  • EE288 Economic Burden and Healthcare Resource Utilization (HCRU) Associated with High-Risk Papillary Stage Ta T1 (PAPTa1) Non-Muscle Invasive Bladder Cancer (NMIBC) Patients, 2008-2019

    Jul 1, 2025, 00:00

  • EPH10 Investigating the Pain Severity and Frequent Exercise Relationship in United States Adults Using the Medical Expenditure Panel Survey

    Jul 1, 2025, 00:00

  • HTA90 Economic Impact of Implementing a Clinical Protocol and Therapeutic Guidelines for Cow's Milk Protein Allergy in Two States of Brazil

    Jul 1, 2025, 00:00

  • EE405 Trial-Based Economic Evaluation of 'Partner in Balance,' a Blended Self-management Program for Early-Stage Dementia Caregivers in the Netherlands: The Health-Economic Analysis Plan and Baseline Results

    Jul 1, 2025, 00:00

  • RWD40 Real World Treatment Patterns for Castration-Sensitive Prostate Cancer Between 2012 and 2024 : A Systematic Review

    Jul 1, 2025, 00:00

  • MSR115 Prediction of Myasthenia Gravis (MG) Crisis Events by a Machine Learning (ML) Algorithm

    Jul 1, 2025, 00:00

  • HPR57 Comparing the Social and Private Value Created by Pembrolizumab 2014-2022

    Jul 1, 2025, 00:00

  • EE392 State of Evidence on Cost-Effectiveness Analysis of Health Technologies in Colombia: A Systematic Literature Review

    Jul 1, 2025, 00:00

  • PCR184 Measuring and Reporting Health-Related Quality of Life (HRQoL) in Locally Advanced/Metastatic Urothelial Cancer (La/mUC) Research: Capturing Outcomes That Really Matter to Patients

    Jul 1, 2025, 00:00

  • RWD150 The HER2-TRENDS StudyHR Positive - HER2 Negative Metastatic Breast Cancer (mBC) Treatment Patterns and Clinical Outcomes in Canada

    Jul 1, 2025, 00:00

  • EE479 Modeling in R: Tutorial for Beginner Using a Cost-Effectiveness Analysis Made With Microsoft Excel

    Jul 1, 2025, 00:00

  • CO91 Real-World Events Often Associated with Relapse (EOAR) Rates Among Patients with Multiple Sclerosis on Natalizumab Using Claims Data from the PearlDiver Mariner Database

    Jul 1, 2025, 00:00

  • HPR70 Revisiting Conflicts in Population-Adjusted Indirect Comparisons: A Duality Perspective

    Jul 1, 2025, 00:00

  • PCR147 Comparison of Rare Disease Patient and Caregiver Perceptions Regarding Access to Disease Information and Interactions with their Healthcare Providers: Results from an International Survey

    Jul 1, 2025, 00:00

  • CO56 Comparison of Selective Serotonin Reuptake Inhibitors and USA Food and Drug Administration-Approved Serotonin-Norepinephrine Reuptake Inhibitors Treatments for Fibromyalgia: A Systematic Review and Network Meta-Analysis

    Jul 1, 2025, 00:00

  • CO45 Systematic Review of Secondary Primary Malignancies (SPMs) in Patients Treated with Chimeric Antigen Receptor T-cell (CAR-T) Therapies

    Jul 1, 2025, 00:00

  • HPR73 Analysis of Out-of-Pocket Payments Associated with Female Infertility in Hungary Between 2015-2023

    Jul 1, 2025, 00:00

  • HSD54 Receipt of Guideline Concordant Treatment Among Older Adults Newly Diagnosed With Stage III - IV Melanoma Using SEER-Medicare Linked Data

    Jul 1, 2025, 00:00

  • PCR31 The Impact of Mucopolysaccharidosis Type III (MPS III) on Family and Finances: A Caregiver Perspective

    Jul 1, 2025, 00:00

  • HPR36 Estimated Impact of the Inflation Reduction Act on Out-of-Pocket Spend Among Medicare Part D Beneficiaries with Cancer

    Jul 1, 2025, 00:00

  • EE477 Healthcare Costs and Resource Utilization Associated With Knee Osteoarthritis and Obesity in the United States: A Retrospective Database Study

    Jul 1, 2025, 00:00

  • CO23 Real-World Effectiveness of Tirzepatide vs. Semaglutide on HbA1c and Weight in GLP-1 RA Naïve Patients with T2D

    Jul 1, 2025, 00:00

  • HPR27 US Food and Drug Administration Approvals, Regulatory Pathways, and Review Time of New Drugs and Biologics, 1980–2024

    Jul 1, 2025, 00:00

  • CO22 Real-World Effectiveness of Alcohol Use Disorder Treatment on Healthcare Utilization and Expenditure Among U.S. Adult Cancer Survivors: A Propensity-Score Matched Cohort Study

    Jul 1, 2025, 00:00

  • MSR146 Identifying Redundant or Misfitting Items Using Item Response Theory: Type I and II Error Rates for Item Local Dependence and Misfit Detection in Clinical Outcome Assessments

    Jul 1, 2025, 00:00

  • Health Impact and Cost-Effectiveness of Testing and Treatment of Mycobacterium Tuberculosis Infection Among Asian and Hispanic Persons With Diagnosed Diabetes in the United States

    Jul 1, 2025, 00:00

  • CO34 Real-World Cancer Recurrence and Overall Survival Outcomes in Muscle-Invasive Bladder Cancer (MIBC) Patients Treated With Radical Cystectomy (RC): A Retrospective Surveillance, Epidemiology, and End Results-Medicare Study

    Jul 1, 2025, 00:00

  • EPH61 Algeria's Healthcare System in 2024: Progress Against Persisting Challenges

    Jul 1, 2025, 00:00

  • EPH162 Real-World Demographic and Clinical Characteristics of Patients With Atherosclerotic Cardiovascular Disease With or Without Chronic Kidney Disease or Systemic Inflammation in the United States

    Jul 1, 2025, 00:00

  • MSR82 Effectiveness of Activity Criteria in Stabilizing Patient Cohorts in Open Claims Data for Healthcare Outcomes Research

    Jul 1, 2025, 00:00

  • HPR64 ICER Thresholds in Cost-Utility Analysis: Assessing Conceptual Relevance and Practical Adequacy for Drug Reimbursement Decision-Making in The US

    Jul 1, 2025, 00:00

  • P62 Characteristics of RWE used in Regulatory Decision-Making for Marketing Authorization Applications (MAAs)

    Jul 1, 2025, 00:00

  • OP8 Framework for Real-World Data Used in Regulatory Submissions

    Jul 1, 2025, 00:00

  • RWD169 Real-World Utilization and Predictors of Neurohormonal Inhibitors Use in Young and Middle-Aged Breast Cancer Patients, Initiating Anthracycline-Based Treatments

    Jul 1, 2025, 00:00

  • PCR9 Empowering Patients in Observational Research: Leveraging Data Insights for Sustained Engagement and Innovation

    Jul 1, 2025, 00:00

  • EPH9 A Retrospective Medical Expenditure Panel Survey Database Study Assessing Factors Associated with Health Status Among United States Adults with Asthma

    Jul 1, 2025, 00:00

  • PCR92 Renal Cell Carcinoma and Muscle Invasive Bladder Cancer Patients' Perception of Risk and Fear of Recurrence

    Jul 1, 2025, 00:00

  • MSR88 Key Considerations in the Use of Large Language Models for Data Extraction in Health Economics and Outcomes Research

    Jul 1, 2025, 00:00

  • EE410 Real-World Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Chronic Lymphocytic Leukemia Treated with Fixed Duration Therapy in a First-Line Setting in Alberta, Canada

    Jul 1, 2025, 00:00

  • EE370 The Costs Associated with Healthcare Resource Use and Work Productivity for Care Partners of Multiple Myeloma Patients in the United States and Europe

    Jul 1, 2025, 00:00

  • EE436 Real World Healthcare Resource Utilization (HRU) and Costs Associated With Mantle Cell Lymphoma (MCL) Therapies in the Frontline (1L) and Relapsed/Refractory (R/R) Setting

    Jul 1, 2025, 00:00

  • PCR156 Frequency and Severity of COVID-19 Acute Symptoms Among Symptomatic US Adults Testing Positive for SARS-CoV-2: Early 2024-2025 Respiratory Season Results of a Nationwide Study

    Jul 1, 2025, 00:00

  • PCR128 Validation of a Questionnaire to Evaluate Simplicity of Diabetes Treatment (SIM-Q)

    Jul 1, 2025, 00:00

  • RWD58 Concomitant Usage of Contra-Indicated Medications in Patients With Atrial Fibrillation: A Comparison of Real-World Data Sources in the United States

    Jul 1, 2025, 00:00

  • EE215 Pompe Disease in Sweden: A Real-World Evidence Study Investigating Healthcare Resource Utilisation and Costs

    Jul 1, 2025, 00:00

  • HSD20 An Analysis of Hospitalization Metrics After Intravenous (IV) Ferric Derisomaltose (FDI) versus Usual Care (UC) in Patients with Iron Deficiency Anemia (IDA) and Heart Failure (HF) Based on IRONMAN

    Jul 1, 2025, 00:00

  • EE294 Economic Burden of Avoidable Blindness Due to Diabetic Macular Edema in Ecuador

    Jul 1, 2025, 00:00

  • RWD157 K2GC: Real-world Treatments and Outcomes Amongst Patients With Resectable Gastric (GC) and Gastroesophageal Junction Cancer (GEJC) in the United States (US)

    Jul 1, 2025, 00:00

  • CO8 Evaluating the Effects of the COVID-19 Pandemic on ICU Mortality and Sedation Charges in Mechanically Ventilated Patients

    Jul 1, 2025, 00:00

  • HPR43 Unlocking the Potential of OBRSAs in the US: Insights on Challenges, Policy Changes, and Pathways Forward

    Jul 1, 2025, 00:00

  • HSD19 Estimating Costs Of Dispensing Services In Community Pharmacies In Taiwan Using A Time-Driven Activity-Based Costing Approach

    Jul 1, 2025, 00:00

  • PCR216 Predicting Future Type 1 Diabetes Onset Risk; A Machine Learning Approach

    Jul 1, 2025, 00:00

  • PCR13 Content Validation of the Patient Attainment Scale-Essential Tremor (PAS-ET): A Novel Patient-Reported Outcome Measure Assessing Patient-Level Perceptions of the Importance, Current Function and Definitions of Meaningful Improvement i ...

    Jul 1, 2025, 00:00

  • OP5 Analysis of the Human Development Index by Innovation In Health, Through the Incorporation of New Technologies In Oncology: Preliminary Data in LMIC/LATAM/Brazil

    Jul 1, 2025, 00:00

  • EPH150 Microbiology Testing and Oral Antibiotic Treatment Among CKD Patients With Urinary Tract Infections: Real-World Evidence From a US EMR Network

    Jul 1, 2025, 00:00

  • EPH152 Trends in Cardiovascular and Cancer Mortality Among Texas Residents with Cancer between 2010 and 2019

    Jul 1, 2025, 00:00

  • EE511 Descriptive Analysis Of Patients With Psoriasis (PSO) Using Biologics Vs. Non-biologics

    Jul 1, 2025, 00:00

  • EPH23 Epidemiology and Disease Burden of Atherosclerotic Cardiovascular Disease, Chronic Kidney Disease, and Systemic Inflammation in Northern China: A Retrospective Study of Tianjin Regional Electronic Health Records

    Jul 1, 2025, 00:00

  • MSR125 Methodology for Estimating Equal Value Life-Year for Standard Three-State Partitioned Survival Models

    Jul 1, 2025, 00:00

  • PT29 Increased Incidence of Parkinson Disease Associated with Antiseizure Medication Use

    Jul 1, 2025, 00:00

  • EPH171 Gabapentinoid Use, Potential Misuse, and Associated Risk Factors among U.S. Adult Cancer Survivors: A Retrospective Cohort Study

    Jul 1, 2025, 00:00

  • EPH136 Demographic Characteristics, Utilization Trends, and Access to GLP-1 Agonists Among Adults in a Nationally Representative Pharmacy Database

    Jul 1, 2025, 00:00

  • HPR171 Comparison of Therapeutic Efficacy by Disease for Outpatients Using Herbal Decoctions Based on the Using the Usage and Consumption of Korean Medicine Report in 2020

    Jul 1, 2025, 00:00

  • EE481 Budget Impact Analysis of Volanesorsen as a Complement to the Diet in Adult Patients with Familial Chylomicronemia Syndrome (FCS) in Mexico

    Jul 1, 2025, 00:00

  • HPR99 Racial and Ethnic Disparities in Orphan Drug Utilization Among Medicare Beneficiaries

    Jul 1, 2025, 00:00

  • EE202 Economic Evaluations of Imaging Guidance for Percutaneous Coronary Interventions: A Scoping Review

    Jul 1, 2025, 00:00

  • EE346 The Clinical Value and Cost-Effectiveness of DefenCath for Reducing Catheter-Related Bloodstream Infections in Adult Patients Receiving Hemodialysis Through a Central Venous Catheter

    Jul 1, 2025, 00:00

  • HPR82 Real-World Evidence in FDA and EMA Regulatory Reviews: Insights on Its Role in Submission Packages and Approvals

    Jul 1, 2025, 00:00

  • PCR98 Enhancing Healthcare Quality through Patient-Centered Outcome Measures in Medicare's Merit-based Incentive Payment System

    Jul 1, 2025, 00:00

  • PCR129 Utility Values From Individuals With Knee Osteoarthritis in the UK

    Jul 1, 2025, 00:00

  • PCR237 Evaluating Thresholds for Minimal Clinically Important Difference (MCID) in Patient-Reported Outcome Measures (PROMs) in Locally Advanced or Metastatic Urothelial Cancer (la/mUC): a Systematic Literature Review (SLR)

    Jul 1, 2025, 00:00

  • HSD25 Efficacy of Improvisational Communication Training for Health Workers in Emergency Care Unit in Hungary: Quazy Experimental Study

    Jul 1, 2025, 00:00

  • CO79 Estimating the Effect of a Discontinued Amyotrophic Lateral Sclerosis Treatment on Time-to-Death Using Sequential Target Trial Emulation

    Jul 1, 2025, 00:00

  • EE463 A Longitudinal Year-by-Year Cost Analysis for Patients Diagnosed with Polycythemia Vera

    Jul 1, 2025, 00:00

  • MT15 RtCGM Use is Associated with Improved Glycemic Control Compared to isCGM in Commercially Insured People with Type 2 Diabetes on Semaglutide and Insulin

    Jul 1, 2025, 00:00

  • Psychometric Performance of a New Condition-Specific Preference-Weighted Measure, Vision Impairment in Low Luminance-Utility Index, and EQ-5D-5L in Patients With Age-Related Macular Degeneration: A MACUSTAR Study Report

    Jul 1, 2025, 00:00

  • PCR186 JAV-RARAS: Evaluation of Adherence to Clinical Protocol and Therapeutic Guidelines (PCDT) for Mucopolysaccharidosis Type 2 (MPS2) at Codajás Polyclinic - An Analysis of the Value-Based Care Journey

    Jul 1, 2025, 00:00

  • RWD44 Clinical Validation of Large Language Model for Automated Extraction of Genetic Testing Data

    Jul 1, 2025, 00:00

  • P32 Oncology Trial Emulation Using Real-World Electronic Health Record Data: Results of the Coalition to Advance Real-World Evidence Through Randomized Controlled Trial Emulation (CARE) Initiative

    Jul 1, 2025, 00:00

  • MSR65 Development of Robust Comprehensive Code Lists to Ensure Consistency Across Global Real-World Evidence Studies

    Jul 1, 2025, 00:00

  • MSR75 Comparison of Generative AI and Manual Data Programming in a Lupus Health Productivity Loss Study

    Jul 1, 2025, 00:00

  • MT39 Real-World Clinical Outcomes, Healthcare Resource Utilization, and Direct Medical Costs in Atrial Fibrillation Patients Receiving Catheter Ablation in Japan

    Jul 1, 2025, 00:00

  • Reviewer Acknowledgment

    Jul 1, 2025, 00:00

  • P46 Probabilistic Attribute Presentation in Discrete Choice Experiments (DCEs): A Review of Current Practice

    Jul 1, 2025, 00:00

  • PCR115 Qualitative Assessment of the Idiopathic Hypersomnia Severity Scale: Suitability for Use As a Clinical Trial Endpoint as Demonstrated in NCT05156047

    Jul 1, 2025, 00:00

  • EE309 Examination of the Two-Year US Commercial Payer Budget Impact (BI) of the Leva Pelvic Health System, a Prescription Medical Device That Provides Supervised Pelvic Floor Muscle Training (PFMT) As First-Line Treatment for Female Urinary ...

    Jul 1, 2025, 00:00

  • EE337 Economic Burden of Rheumatoid Arthritis in Low- and Middle-Income Countries: Systematic Review

    Jul 1, 2025, 00:00

  • HTA96 Navigating Evidence Requirements for Joint Clinical Assessment of Orphan and Advanced Therapy Medicinal Products in Europe

    Jul 1, 2025, 00:00

  • PCR137 Patient and Physician Perspectives on Attributes of IO-Containing? Perioperative Treatments in Potentially Resectable, Non-metastatic Non-small Cell Lung Cancer (NSCLC)

    Jul 1, 2025, 00:00

  • CO5 Patient Journey Prior to the Diagnosis of Niemann-Pick Disease Type C

    Jul 1, 2025, 00:00

  • EPH111 Epidemiology of Polymyalgia Rheumatica: A Targeted Literature Review

    Jul 1, 2025, 00:00

  • RWD166 Use of a Representative Sample of the French National Health Insurance Database (ESND) for Research: A Targeted Literature Review

    Jul 1, 2025, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10 (current)
  • »